Proteasome Activity and Immunosenescence

  • Bertrand Friguet


The proteasome is the main proteolytic system implicated in the removal of oxidatively damaged proteins, general turnover of intracellular proteins and targeted degradation of proteins that have been marked by poly-ubiquitination. Impairment of proteasome function has been associated with cellular aging in a variety of tissues and cell types including lymphocytes, and is believed to contribute to the age-related accumulation of oxidized proteins due to their decreased elimination by the proteasomal pathway. This chapter first summarizes the most relevant features of the proteasomal system and then expands on the current knowledge on the impact of aging on proteasome structure and function, taking in account the fate of proteasome upon oxidative stress situations. Finally, the possible implication of age-related alterations of the proteasomal system in the process of immunosenescence is presented.

Proteasome Aging Protein oxidation Damaged protein degradation Immunosenescence 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Adams J, Behnke M, Chen S, Cruickshank AA, Dick LR, Grenier L, Klunder JM, Ma YT, Plamondon L, Stein RL (1998) Potent and selective inhibitors of the proteasome: dipeptidyl boronic acids. Bioorg Med Chem Lett 8:333–338PubMedCrossRefGoogle Scholar
  2. Adams J, Kauffman M (2004) Development of the proteasome inhibitor Velcade (Bortezomib). Cancer Invest 22:304–311PubMedCrossRefGoogle Scholar
  3. Ahn JY, Tanahashi N, Akiyama K, Hisamatsu H, Noda C, Tanaka K, Chung CH, Shibmara N, Willy PJ, Mott JD, et al (1995) Primary structures of two homologous subunits of PA28, a gamma-interferon-inducible protein activator of the 20S proteasome. FEBS Lett 366:37–42PubMedCrossRefGoogle Scholar
  4. Ando H, Watabe H, Valencia JC, Yasumoto K, Furumura M, Funasaka Y, Oka M, Ichihashi M, Hearing VJ (2004) Fatty acids regulate pigmentation via proteasomal degradation of tyrosinase: a new aspect of ubiquitin-proteasome function. J Biol Chem 279:15427–15433PubMedCrossRefGoogle Scholar
  5. Anselmi B, Conconi M, Veyrat-Durebex C, Turlin E, Biville F, Alliot J, Friguet B (1998) Dietary self-selection can compensate an age-related decrease of rat liver 20 S proteasome ac tivity observed with standard diet. J Gerontol A Biol Sci Med Sci 53:B173–B179PubMedGoogle Scholar
  6. Arrigo AP (2001) Hsp27: novel regulator of intracellular redox state. IUBMB Life 52:303–307PubMedCrossRefGoogle Scholar
  7. Bardag-Gorce F, Farout L, Veyrat-Durebex C, Briand Y, Briand M (1999) Changes in 20S proteasome activity during ageing of the LOU rat. Mol Biol Rep 26:89–93PubMedCrossRefGoogle Scholar
  8. Basse N, Papapostolou D, Pagano M, Reboud-Ravaux M, Bernard E, Felten AS, Vanderesse R (2006) Development of lipopeptides for inhibiting 20S proteasomes. Bioorg Med Chem Lett 16:3277–3281PubMedCrossRefGoogle Scholar
  9. Beckman KB, Ames BN (1998) The free radical theory of aging matures. Physiol Rev 78:547–581PubMedGoogle Scholar
  10. Ben-Yehuda A, Danenberg HD, Zakay-Rones Z, Gross DJ, Friedman G (1998) The influence of sequential annual vaccination and of DHEA administration on the efficacy of the immune response to influenza vaccine in the elderly. Mech Ageing Dev 102:299–306PubMedCrossRefGoogle Scholar
  11. Beregi E, Regius O, Rajczy K (1991) Comparative study of the morphological changes in lymphocytes of elderly individuals and centenarians. Age Ageing 20:55–59PubMedCrossRefGoogle Scholar
  12. Berlett BS, Stadtman ER (1997) Protein oxidation in aging, disease, and oxidative stress. J Biol Chem 272:20313–20316PubMedCrossRefGoogle Scholar
  13. Bogyo M, McMaster JS, Gaczynska M, Tortorella D, Goldberg AL, Ploegh H (1997). Covalent modification of the active site threonine of proteasomal beta subunits and the Escherichia coli homolog HslV by a new class of inhibitors. Proc Natl Acad Sci U S A 94:6629–6634PubMedCrossRefGoogle Scholar
  14. Borissenko L, Groll M (2007). 20S proteasome and its inhibitors: crystallographic knowledge for drug development. Chem Rev 107:687–717PubMedCrossRefGoogle Scholar
  15. Braun BC, Glickman M, Kraft R, Dahlmann B, Kloetzel PM, Finley D, Schmidt M (1999) The base of the proteasome regulatory particle exhibits chaperone-like activity. Nat Cell Biol 1:221–226PubMedCrossRefGoogle Scholar
  16. Braun HA, Umbreen S, Groll M, Kuckelkorn U, Mlynarczuk I, Wigand ME, Drung I, Kloetzel PM, Schmidt B (2005) Tripeptide mimetics inhibit the 20 S proteasome by covalent bonding to the active threonines. J Biol Chem 280:28394–28401PubMedCrossRefGoogle Scholar
  17. Bulteau AL, Lundberg KC, Humphries KM, Sadek HA, Szweda PA, Friguet B, Szweda LI (2001a). Oxidative modification and inactivation of the proteasome during coronary occlusion/reperfusion. J Biol Chem 276:30057–30063CrossRefGoogle Scholar
  18. Bulteau AL, Moreau M, Nizard C, Friguet B (2002a) Impairment of proteasome function upon UVA- and UVB-irradiation of human keratinocytes. Free Radic Biol Med 32:1157–1170CrossRefGoogle Scholar
  19. Bulteau AL, Petropoulos I, Friguet B (2000) Age-related alterations of proteasome structure and function in aging epidermis. Exp Gerontol 35:767–777PubMedCrossRefGoogle Scholar
  20. Bulteau AL, Szweda LI, Friguet B (2002b) Age-dependent declines in proteasome activity in the heart. Arch Biochem Biophys 397:298–304CrossRefGoogle Scholar
  21. Bulteau AL, Verbeke P, Petropoulos I, Chaffotte AF, Friguet B (2001b). Proteasome inhibition in glyoxal-treated fibroblasts and resistance of glycated glucose-6-phosphate dehydrogenase to 20 S proteasome degradation in vitro. J Biol Chem 276:45662–45668CrossRefGoogle Scholar
  22. Carrard G, Bulteau AL, Petropoulos I, Friguet B (2002) Impairment of proteasome structure and function in aging. Int J Biochem Cell Biol 34:1461–1474PubMedCrossRefGoogle Scholar
  23. Carrard G, Dieu M, Raes M, Toussaint O, Friguet B (2003) Impact of ageing on proteasome structure and function in human lymphocytes. Int J Biochem Cell Biol 35:728–739PubMedCrossRefGoogle Scholar
  24. Chondrogianni N, Petropoulos I, Franceschi C, Friguet B, Gonos ES (2000). Fibroblast cultures from healthy centenarians have an active proteasome. Exp Gerontol 35:721–728PubMedCrossRefGoogle Scholar
  25. Chondrogianni N, Stratford FL, Trougakos IP, Friguet B, Rivett AJ, Gonos ES (2003) Central role of the proteasome in senescence and survival of human fibroblasts: induction of a senescencelike phenotype upon its inhibition and resistance to stress upon its activation. J Biol Chem 278:28026–28037PubMedCrossRefGoogle Scholar
  26. Ciechanover A, Iwai K (2004) The ubiquitin system: from basic mechanisms to the patient bed. IUBMB Life 56:193–201PubMedCrossRefGoogle Scholar
  27. Conconi M, Friguet B (1997). Proteasome inactivation upon aging and on oxidation-effect of HSP 90. Mol Biol Rep 24:45–50PubMedCrossRefGoogle Scholar
  28. Conconi M, Petropoulos I, Emod I, Turlin E, Biville F, Friguet B (1998) Protection from oxidative inactivation of the 20S proteasome by heat-shock protein 90. Biochem J 333 (Pt 2):407–415.PubMedGoogle Scholar
  29. Conconi M, Szweda LI, Levine RL, Stadtman ER, Friguet B (1996) Age-related decline of rat liver multicatalytic proteinase activity and protection from oxidative inactivation by heat-shock protein 90. Arch Biochem Biophys 331:232–240PubMedCrossRefGoogle Scholar
  30. Coux O, Tanaka K, Goldberg AL (1996) Structure and functions of the 20S and 26S proteasomes. Annu Rev Biochem 65:801–847PubMedCrossRefGoogle Scholar
  31. Dahlmann B (2005) Proteasomes. Essays Biochem 41:31–48PubMedCrossRefGoogle Scholar
  32. Dahlmann B, Rutschmann M, Kuehn L, Reinauer H (1985) Activation of the multicatalytic proteinase from rat skeletal muscle by fatty acids or sodium dodecyl sulphate. Biochem J 228:171–177PubMedGoogle Scholar
  33. Das R, Ponnappan S, Ponnappan U (2007) Redox regulation of the proteasome in T lymphocytes during aging. Free Radic Biol Med 42:541–551PubMedCrossRefGoogle Scholar
  34. Davies KJ (2001). Degradation of oxidized proteins by the 20S proteasome. Biochimie 83:301–310PubMedCrossRefGoogle Scholar
  35. Davies KJ (1987) Protein damage and degradation by oxygen radicals. I. general aspects. J Biol Chem 262:9895–9901PubMedGoogle Scholar
  36. Davies KJ (1993) Protein modification by oxidants and the role of proteolytic enzymes. Biochem Soc Trans 21:346–353PubMedGoogle Scholar
  37. Dean RT, Fu S, Stocker R, Davies MJ (1997) Biochemistry and pathology of radical-mediated protein oxidation. Biochem J 324 (Pt 1):1–18PubMedGoogle Scholar
  38. Deng GY, Muir A, Maclaren NK, She JX (1995) Association of LMP2 and LMP7 genes within the major histocompatibility complex with insulin-dependent diabetes mellitus: population and family studies. Am J Hum Genet 56:528–534PubMedGoogle Scholar
  39. Deveraux Q, Ustrell V, Pickart C, Rechsteiner M (1994) A 26 S protease subunit that binds ubiquitin conjugates. J Biol Chem 269:7059–7061PubMedGoogle Scholar
  40. Diaz-Hernandez M, Hernandez F, Martin-Aparicio E, Gomez-Ramos P, Moran MA, Castano JG, Ferrer I, Avila J, Lucas JJ (2003). Neuronal induction of the immunoproteasome in Huntington’s disease. J Neurosci 23:11653–11661PubMedGoogle Scholar
  41. Diaz-Hernandez M, Martin-Aparicio E, Avila J, Hernandez F, Lucas JJ (2004) Enhanced induction of the immunoproteasome by interferon gamma in neurons expressing mutant Huntingtin. Neurotox Res 6:463–468PubMedGoogle Scholar
  42. Ding Q, Keller JN (2001) Proteasome inhibition in oxidative stress neurotoxicity: implications for heat shock proteins. J Neurochem 77:1010–1017PubMedCrossRefGoogle Scholar
  43. Ding Q, Reinacker K, Dimayuga E, Nukala V, Drake J, Butterfield DA, Dunn JC, Martin S, Bruce- Keller AJ, Keller JN (2003) Role of the proteasome in protein oxidation and neural viability following low-level oxidative stress. FEBS Lett 546:228–232PubMedCrossRefGoogle Scholar
  44. Ditzel L, Huber R, Mann K, Heinemeyer W, Wolf DH, Groll M (1998) Conformational constraints for protein self-cleavage in the proteasome. J Mol Biol 279:1187–1191PubMedCrossRefGoogle Scholar
  45. Dubiel W, Pratt G, Ferrell K, Rechsteiner M (1992) Purification of an 11 S regulator of the multicatalytic protease. J Biol Chem 267:22369–22377PubMedGoogle Scholar
  46. Dunn PL, North RJ (1991) Effect of advanced ageing on the ability of mice to cause tumour regression in response to immunotherapy. Immunology 74:355–359PubMedGoogle Scholar
  47. Elofsson M, Splittgerber U, Myung J, Mohan R, Crews CM (1999) Towards subunit-specific proteasome inhibitors: synthesis and evaluation of peptide alpha’,beta’-epoxyketones. Chem Biol 6:811–822PubMedCrossRefGoogle Scholar
  48. Farout L, Mary J, Vihn J, Szweda LI, Friguet B (2006). Inactivation of the Proteasome by 4- Hydroxy-2-nonenal is site specific and dependant on 20S proteasome subtypes. Arch Biochem Biophys (in press)Google Scholar
  49. Fenteany, G., Standaert, R.F., Lane, W.S., Choi, S., Corey EJ, Schreiber SL (1995) Inhibition of proteasome activities and subunit-specific amino-terminal threonine modification by lactacystin. Science 268:726–731PubMedCrossRefGoogle Scholar
  50. Ferrington DA, Husom AD, Thompson LV (2005) Altered proteasome structure, function, and oxidation in aged muscle. FASEB J 19:644–646PubMedGoogle Scholar
  51. Ferrington DA, Kapphahn RJ (2004) Catalytic site-specific inhibition of the 20S proteasome by 4-hydroxynonenal. FEBS Lett 578:217–223PubMedCrossRefGoogle Scholar
  52. Finley D, Ciechanover A, Varshavsky A (2004) Ubiquitin as a central cellular regulator. Cell 116: S29–S32, 2 p following S32Google Scholar
  53. Fisher MT, Stadtman ER (1992) Oxidative modification of Escherichia coli glutamine synthetase. Decreases in the thermodynamic stability of protein structure and specific changes in the active site conformation. J Biol Chem 267:1872–1880PubMedGoogle Scholar
  54. Friguet B (2006) Oxidized protein degradation and repair in ageing and oxidative stress. FEBS Lett 580:2910–2916PubMedCrossRefGoogle Scholar
  55. Friguet B, Bulteau AL, Chondrogianni N, Conconi M, Petropoulos I (2000) Protein degradation by the proteasome and its implications in aging. Ann N Y Acad Sci 908:143–154PubMedGoogle Scholar
  56. Friguet B, Stadtman ER, Szweda LI (1994a) Modification of glucose-6-phosphate dehydrogenase by 4-hydroxy-2-nonenal. Formation of cross-linked protein that inhibits the multicatalytic protease. J Biol Chem 269:21639–21643Google Scholar
  57. Friguet B, Szweda LI (1997) Inhibition of the multicatalytic proteinase (proteasome) by 4-hydroxy- 2-nonenal cross-linked protein. FEBS Lett 405:21–25PubMedCrossRefGoogle Scholar
  58. Friguet B, Szweda LI, Stadtman ER (1994b) Susceptibility of glucose-6-phosphate dehydrogenase modified by 4-hydroxy-2-nonenal and metal-catalyzed oxidation to proteolysis by the multicatalytic protease. Arch Biochem Biophys 311:168–173CrossRefGoogle Scholar
  59. Fruh K, Gossen M, Wang K, Bujard H, Peterson PA, Yang Y (1994). Displacement of housekeeping proteasome subunits by MHC-encoded LMPs: a newly discovered mechanism for modulating the multicatalytic proteinase complex. EMBO J 13:3236–3244PubMedGoogle Scholar
  60. Furet P, Imbach P, Noorani M, Koeppler J, Laumen K, Lang M, Guagnano V, Fuerst P, Roesel J, Zimmermann J, Garcia-Echeverria C (2004). Entry into a new class of potent proteasome inhibitors having high antiproliferative activity by structure-based design. J Med Chem 47:4810–4813PubMedCrossRefGoogle Scholar
  61. Gaczynska M, Osmulski PA, Ward WF (2001) Caretaker or undertaker? The role of the proteasome in aging. Mech Ageing Dev 122:235–254PubMedCrossRefGoogle Scholar
  62. Gaczynska M, Rock KL, Goldberg AL (1993) Gamma-interferon and expression of MHC genes regulate peptide hydrolysis by proteasomes. Nature 365:264–267PubMedCrossRefGoogle Scholar
  63. Gerards WL, de Jong WW, Bloemendal H, Boelens W (1998) The human proteasomal subunit HsC8 induces ring formation of other alpha-type subunits. J Mol Biol 275:113–121PubMedCrossRefGoogle Scholar
  64. Ginaldi L, Loreto MF, Corsi MP, Modesti M, De Martinis M (2001). Immunosenescence and infectious diseases. Microbes Infect 3:851–857PubMedCrossRefGoogle Scholar
  65. Glockzin S, von Knethen A, Scheffner M, Brune B (1999) Activation of the cell death program by nitric oxide involves inhibition of the proteasome. J Biol Chem 274:19581–19586PubMedCrossRefGoogle Scholar
  66. Goldberg AL, Akopian TN, Kisselev AF, Lee DH, Rohrwild M (1997) New insights into the mechanisms and importance of the proteasome in intracellular protein degradation. Biol Chem 378:131–140PubMedGoogle Scholar
  67. Goto S, Takahashi R, Araki S, Nakamoto H (2002) Dietary restriction initiated in late adulthood can reverse age-related alterations of protein and protein metabolism. Ann N Y Acad Sci 959:50–56PubMedGoogle Scholar
  68. Gravekamp C (2001) Tailoring cancer vaccines to the elderly: the importance of suitable mouse models. Mech Ageing Dev 122:1087–1105PubMedCrossRefGoogle Scholar
  69. Grimaud R, Ezraty B, Mitchell JK, Lafitte D, Briand C, Derrick PJ, Barras F (2001). Repair of oxidized proteins. Identification of a new methionine sulfoxide reductase. J Biol Chem 276:48915–48920PubMedCrossRefGoogle Scholar
  70. Groll M, Ditzel L, Lowe J, Stock D, Bochtler M, Bartunik HD, Huber R (1997) Structure of 20S proteasome from yeast at 2.4 A resolution. Nature 386:463–471PubMedCrossRefGoogle Scholar
  71. Groll M, Heinemeyer W, Jager S, Ullrich T, Bochtler M, Wolf DH, Huber R (1999) The catalytic sites of 20S proteasomes and their role in subunit maturation: a mutational and crystallographic study. Proc Natl Acad Sci U S A 96:10976–10983PubMedCrossRefGoogle Scholar
  72. Groll M, Koguchi Y, Huber R, Kohno J (2001) Crystal structure of the 20 S proteasome:TMC-95A complex: a non-covalent proteasome inhibitor. J Mol Biol 311:543–548PubMedCrossRefGoogle Scholar
  73. Grune T, Reinheckel T, Davies KJ (1997) Degradation of oxidized proteins in mammalian cells. FASEB J 11:526–534PubMedGoogle Scholar
  74. Hamelin M, Mary J, Vostry M, Friguet B, Bakala H (2007) Glycation damage targets glutamate dehydrogenase in the rat liver mitochondrial matrix during aging. FEBS J 274:5949–5961PubMedCrossRefGoogle Scholar
  75. Harris JR (1968) Release of a macromolecular protein component from human erythrocyte ghosts. Biochim Biophys Acta 150:534–537PubMedCrossRefGoogle Scholar
  76. Hayashi T, Goto S (1998) Age-related changes in the 20S and 26S proteasome activities in the liver of male F344 rats. Mech Ageing Dev 102:55–66PubMedCrossRefGoogle Scholar
  77. Hegerl R, Pfeifer G, Puhler G, Dahlmann B, Baumeister W (1991) The three-dimensional structure of proteasomes from Thermoplasma acidophilum as determined by electron microscopy using random conical tilting. FEBS Lett 283:117–121PubMedCrossRefGoogle Scholar
  78. Hensley K, Floyd RA (2002) Reactive oxygen species and protein oxidation in aging: a look back, a look ahead. Arch Biochem Biophys 397:377–383PubMedCrossRefGoogle Scholar
  79. Hershko A, Ciechanover A (1998) The ubiquitin system. Annu Rev Biochem 67:425–479PubMedCrossRefGoogle Scholar
  80. Hoglinger GU, Carrard G, Michel PP, Medja F, Lombes A, Ruberg M, Friguet B, Hirsch EC (2003) Dysfunction of mitochondrial complex I and the proteasome: interactions between two biochemical deficits in a cellular model of Parkinson’s disease. J Neurochem 86:1297–1307PubMedGoogle Scholar
  81. Holmgren A (2000) Antioxidant function of thioredoxin and glutaredoxin systems. Antioxid Redox Signal 2:811–820PubMedCrossRefGoogle Scholar
  82. Kageshita T, Hirai S, Ono T, Hicklin DJ, Ferrone S (1999) Down-regulation of HLA class I antigen-processing molecules in malignant melanoma: association with disease progression. Am J Pathol 154:745–754PubMedGoogle Scholar
  83. Keller JN, Hanni KB, Markesbery WR (2000a) Possible involvement of proteasome inhibition in aging: implications for oxidative stress. Mech Ageing Dev 113:61–70CrossRefGoogle Scholar
  84. Keller JN, Huang FF, Markesbery WR (2000b) Decreased levels of proteasome activity and proteasome expression in aging spinal cord. Neuroscience 98:149–156CrossRefGoogle Scholar
  85. Keller JN, Huang FF, Zhu H, Yu J, Ho YS, Kindy TS (2000c) Oxidative stress-associated impairment of proteasome activity during ischemia-reperfusion injury. J Cereb Blood Flow Metab 20:1467–1473CrossRefGoogle Scholar
  86. Kiffin R, Christian C, Knecht E, Cuervo AM (2004) Activation of chaperone-mediated autophagy during oxidative stress. Mol Biol Cell 15:4829–4840PubMedCrossRefGoogle Scholar
  87. King RW, Deshaies RJ, Peters JM, Kirschner MW (1996) How proteolysis drives the cell cycle. Science 274:1652–1659PubMedCrossRefGoogle Scholar
  88. Kisselev AF, Akopian TN, Castillo V, Goldberg AL (1999) Proteasome active sites allosterically regulate each other, suggesting a cyclical bite-chew mechanism for protein breakdown. Mol Cell 4:395–402PubMedCrossRefGoogle Scholar
  89. Kline GH, Hayden TA, Klinman NR (1999) B cell maintenance in aged mice reflects both increased B cell longevity and decreased B cell generation. J Immunol 162:3342–3349PubMedGoogle Scholar
  90. Klionsky DJ (2005) The molecular machinery of autophagy: unanswered questions. J Cell Sci 118:7–18PubMedCrossRefGoogle Scholar
  91. Kloetzel PM (2001) Antigen processing by the proteasome. Nat Rev Mol Cell Biol 2:179–187PubMedCrossRefGoogle Scholar
  92. Kloetzel PM (2004) The proteasome and MHC class I antigen processing. Biochim Biophys Acta 1695:225–233PubMedCrossRefGoogle Scholar
  93. Knowlton JR, Johnston SC, Whitby FG, Realini C, Zhang Z, Rechsteiner M, Hill CP (1997) Structure of the proteasome activator REGalpha (PA28alpha). Nature 390:639–643PubMedCrossRefGoogle Scholar
  94. Koguchi Y, Kohno J, Nishio M, Takahashi K, Okuda T, Ohnuki T, Komatsubara S (2000) TMC-95A, B, C, and D, novel proteasome inhibitors produced by Apiospora montagnei Sacc. TC 1093. Taxonomy, production, isolation, and biological activities. J Antibiot (Tokyo) 53:105–109Google Scholar
  95. Kohler A, Cascio P, Leggett DS, Woo KM, Goldberg AL, Finley D (2001) The axial channel of the proteasome core particle is gated by the Rpt2 ATPase and controls both substrate entry and product release. Mol Cell 7:1143–1152PubMedCrossRefGoogle Scholar
  96. Kroll M, Arenzana-Seisdedos F, Bachelerie F, Thomas D, Friguet B, Conconi M (1999) The secondary fungal metabolite gliotoxin targets proteolytic activities of the proteasome. Chem Biol 6:689–698PubMedCrossRefGoogle Scholar
  97. Lee CK, Klopp RG, Weindruch R, Prolla TA (1999) Gene expression profile of aging and its retardation by caloric restriction. Science 285:1390–1393PubMedCrossRefGoogle Scholar
  98. Levine RL, Stadtman ER (2001) Oxidative modification of proteins during aging. Exp Gerontol 36:1495–1502PubMedCrossRefGoogle Scholar
  99. Levine RL, Williams JA, Stadtman ER, Shacter E (1994) Carbonyl assays for determination of oxidatively modified proteins. Methods Enzymol 233:346–357PubMedCrossRefGoogle Scholar
  100. Loidl G, Groll M, Musiol HJ, Huber R, Moroder L (1999) Bivalency as a principle for proteasome inhibition. Proc Natl Acad Sci U S A 96:5418–5422PubMedCrossRefGoogle Scholar
  101. Lowe J, Stock D, Jap B, Zwickl P, Baumeister W, Huber R (1995) Crystal structure of the 20S proteasome from the archaeon T. acidophilum at 3.4 A resolution. Science 268:533–539PubMedCrossRefGoogle Scholar
  102. Ly DH, Lockhart DJ, Lerner RA, Schultz PG (2000) Mitotic misregulation and human aging. Science 287:2486–2492PubMedCrossRefGoogle Scholar
  103. Ma CP, Slaughter CA, DeMartino GN (1992) Identification, purification, and characterization of a protein activator (PA28) of the 20 S proteasome (macropain). J Biol Chem 267:10515–10523PubMedGoogle Scholar
  104. Marastoni M, Baldisserotto A, Canella A, Gavioli R, Risi CD, Pollini GP, Tomatis R (2004) Arecoline tripeptide inhibitors of proteasome. J Med Chem 47:1587–1590PubMedCrossRefGoogle Scholar
  105. Marques C, Pereira P, Taylor A, Liang JN, Reddy VN, Szweda LI, Shang F (2004) Ubiquitindependent lysosomal degradation of the HNE-modified proteins in lens epithelial cells. FASEB J 18:1424–1426PubMedGoogle Scholar
  106. Mason GG, Murray RZ, Pappin D, Rivett AJ (1998) Phosphorylation of ATPase subunits of the 26S proteasome. FEBS Lett 430:269–274PubMedCrossRefGoogle Scholar
  107. Meidenbauer N, Zippelius A, Pittet MJ, Laumer M, Vogl S, Heymann J, Rehli M, Seliger B, Schwarz S, Le Gal FA, Dietrich PY, Andreesen R, Romero P, Mackensen A (2004) High frequency of functionally active Melan-a-specific T cells in a patient with progressive immunoproteasome- deficient melanoma. Cancer Res 64:6319–6326PubMedCrossRefGoogle Scholar
  108. Merker K, Sitte N, Grune T (2000) Hydrogen peroxide-mediated protein oxidation in young and old human MRC-5 fibroblasts. Arch Biochem Biophys 375:50–54PubMedCrossRefGoogle Scholar
  109. Miller RA (2000) Effect of aging on T lymphocyte activation. Vaccine 18:1654–1660PubMedCrossRefGoogle Scholar
  110. Mishto M, Bonafe M, Salvioli S, Olivieri F, Franceschi C (2002) Age dependent impact of LMP polymorphisms on TNFalpha-induced apoptosis in human peripheral blood mononuclear cells. Exp Gerontol 37:301–308PubMedCrossRefGoogle Scholar
  111. Mott JD, Pramanik BC, Moomaw CR, Afendis SJ, DeMartino GN, Slaughter CA (1994) PA28, an activator of the 20 S proteasome, is composed of two nonidentical but homologous subunits. J Biol Chem 269:31466–31471PubMedGoogle Scholar
  112. Murakami Y, Kanda K, Yokota K, Kanayama H, Kagawa S (2001) Prognostic significance of immuno-proteosome subunit expression in patients with renal-cell carcinoma: a preliminary study. Mol Urol 5:113–119PubMedCrossRefGoogle Scholar
  113. Okada K, Wangpoengtrakul C, Osawa T, Toyokuni S, Tanaka K, Uchida K (1999) 4-Hydroxy-2- nonenal-mediated impairment of intracellular proteolysis during oxidative stress. Identification of proteasomes as target molecules. J Biol Chem 274:23787–23793PubMedCrossRefGoogle Scholar
  114. Orr WC, Sohal RS (1994) Extension of life-span by overexpression of superoxide dismutase and catalase in Drosophila melanogaster. Science 263:1128–1130PubMedCrossRefGoogle Scholar
  115. Pajonk F, McBride WH (2001) The proteasome in cancer biology and treatment. Radiat Res 156:447–459PubMedCrossRefGoogle Scholar
  116. Petropoulos I, Conconi M, Wang X, Hoenel B, Bregegere F, Milner Y, Friguet B (2000) Increase of oxidatively modified protein is associated with a decrease of proteasome activity and content in aging epidermal cells. J Gerontol A Biol Sci Med Sci 55:B220–B227PubMedGoogle Scholar
  117. Pimentel-Muinos FX, Mazana J, Fresno M (1994) Regulation of interleukin-2 receptor alpha chain expression and nuclear factor.kappa B activation by protein kinase C in T lymphocytes. Autocrine role of tumor necrosis factor alpha. J Biol Chem 269:24424–24429PubMedGoogle Scholar
  118. Poggioli S, Bakala H, Friguet B (2002) Age-related increase of protein glycation in peripheral blood lymphocytes is restricted to preferential target proteins. Exp Gerontol 37:1207–1215PubMedCrossRefGoogle Scholar
  119. Poggioli S, Mary J, Bakala H, Friguet B (2004) Evidence of preferential protein targets for agerelated modifications in peripheral blood lymphocytes. Ann N Y Acad Sci 1019:211–214PubMedCrossRefGoogle Scholar
  120. Ponnappan S, Ovaa H, Ponnappan U (2007) Lower expression of catalytic and structural subunits of the proteasome contributes to decreased proteolysis in peripheral blood T lymphocytes during aging. Int J Biochem Cell Biol 39:799–809PubMedCrossRefGoogle Scholar
  121. Ponnappan U (1998) Regulation of transcription factor NF kappa B in immune senescence. Front Biosci 3:d152–d168PubMedGoogle Scholar
  122. Ponnappan U (2002) Ubiquitin-proteasome pathway is compromised in CD45RO+ and CD45RA+ T lymphocyte subsets during aging. Exp Gerontol 37:359–367PubMedCrossRefGoogle Scholar
  123. Ponnappan U, Zhong M, Trebilcock GU (1999) Decreased proteasome-mediated degradation in T cells from the elderly: A role in immune senescence. Cell Immunol 192:167–174PubMedCrossRefGoogle Scholar
  124. Poole LB, Karplus PA, Claiborne A (2004) Protein sulfenic acids in redox signaling. Annu Rev Pharmacol Toxicol 44:325–347PubMedCrossRefGoogle Scholar
  125. Powell SR, Wang P, Divald A, Teichberg S, Haridas V, McCloskey TW, Davies KJ, Katzeff H (2005) Aggregates of oxidized proteins (lipofuscin) induce apoptosis through proteasome inhibition and dysregulation of proapoptotic proteins. Free Radic Biol Med 38:1093–1101PubMedCrossRefGoogle Scholar
  126. Pryhuber KG, Murray KJ, Donnelly P, Passo MH, Maksymowych WP, Glass DN, Giannini EH, Colbert RA (1996) Polymorphism in the LMP2 gene influences disease susceptibility and severity in HLA-B27 associated juvenile rheumatoid arthritis. J Rheumatol 23:747–752PubMedGoogle Scholar
  127. Reinheckel T, Sitte N, Ullrich O, Kuckelkorn U, Davies KJ, Grune T (1998) Comparative resistance of the 20S and 26S proteasome to oxidative stress. Biochem J 335 (Pt 3):637–642PubMedGoogle Scholar
  128. Requena JR, Levine RL, Stadtman ER (2003) Recent advances in the analysis of oxidized proteins. Amino Acids 25:221–226PubMedCrossRefGoogle Scholar
  129. Rivett AJ, Hearn AR (2004) Proteasome function in antigen presentation: immunoproteasome complexes, Peptide production, and interactions with viral proteins. Curr Protein Pept Sci 5:153–161PubMedCrossRefGoogle Scholar
  130. Rock KL, Goldberg, AL (1999) Degradation of cell proteins and the generation of MHC class Ipresented peptides. Annu Rev Immunol 17, 739–779PubMedCrossRefGoogle Scholar
  131. Schmidtke G, Holzhutter HG, Bogyo M, Kairies N, Groll M, de Giuli R, Emch S, Groettrup M (1999) How an inhibitor of the HIV-I protease modulates proteasome activity. J Biol Chem 274:35734–35740PubMedCrossRefGoogle Scholar
  132. Sell DR, Primc M, Schafer IA, Kovach M, Weiss MA, Monnier VM (1998) Cell-associated pentosidine as a marker of aging in human diploid cells in vitro and in vivo. Mech Ageing Dev 105:221–240PubMedCrossRefGoogle Scholar
  133. Shamoto-Nagai M, Maruyama W, Kato Y, Isobe K, Tanaka M, Naoi M, Osawa T (2003) An inhibitor of mitochondrial complex I, rotenone, inactivates proteasome by oxidative modification and induces aggregation of oxidized proteins in SH-SY5Y cells. J Neurosci Res 74:589–597PubMedCrossRefGoogle Scholar
  134. Shang F, Nowell TR Jr, Taylor A (2001) Removal of oxidatively damaged proteins from lens cells by the ubiquitin-proteasome pathway. Exp Eye Res 73:229–238PubMedCrossRefGoogle Scholar
  135. Sharov VS, Ferrington DA, Squier TC, Schoneich C (1999) Diastereoselective reduction of protein- bound methionine sulfoxide by methionine sulfoxide reductase. FEBS Lett 455:247–250PubMedCrossRefGoogle Scholar
  136. Shibatani T, Nazir M, Ward WF (1996) Alteration of rat liver 20S proteasome activities by age and food restriction. J Gerontol A Biol Sci Med Sci 51:B316–B322PubMedGoogle Scholar
  137. Shibatani T, Ward WF (1996) Effect of age and food restriction on alkaline protease activity in rat liver. J Gerontol A Biol Sci Med Sci 51:B175–B178PubMedGoogle Scholar
  138. Shringarpure R, Grune T, Mehlhase J, Davies KJ (2003) Ubiquitin conjugation is not required for the degradation of oxidized proteins by proteasome. J Biol Chem 278:311–318PubMedCrossRefGoogle Scholar
  139. Sitte N, Huber M, Grune T, Ladhoff A, Doecke WD, Von Zglinicki T, Davies KJ (2000). Proteasome inhibition by lipofuscin/ceroid during postmitotic aging of fibroblasts. FASEB J 14:1490–1498PubMedCrossRefGoogle Scholar
  140. Stacy S, Krolick KA, Infante AJ, Kraig E (2002) Immunological memory and late onset autoimmunity. Mech Ageing Dev 123:975–985PubMedCrossRefGoogle Scholar
  141. Stadtman ER (1990) Metal ion-catalyzed oxidation of proteins: biochemical mechanism and biological consequences. Free Radic Biol Med 9:315–325PubMedCrossRefGoogle Scholar
  142. Stadtman ER (2006) Protein oxidation and aging. Free Radic Res 40:1250–1258PubMedCrossRefGoogle Scholar
  143. Stadtman ER, Levine RL (2003) Free radical-mediated oxidation of free amino acids and amino acid residues in proteins. Amino Acids 25:207–218PubMedCrossRefGoogle Scholar
  144. Stadtman ER, Levine RL (2000) Protein oxidation. Ann N Y Acad Sci 899:191–208PubMedCrossRefGoogle Scholar
  145. Stratford FL, Chondrogianni N, Trougakos IP, Gonos ES, Rivett AJ (2006) Proteasome response to interferon-gamma is altered in senescent human fibroblasts. FEBS Lett 580:3989–3994PubMedCrossRefGoogle Scholar
  146. Sullivan PG, Dragicevic NB, Deng JH, Bai Y, Dimayuga E, Ding Q, Chen Q, Bruce-Keller AJ, Keller JN (2004). Proteasome inhibition alters neural mitochondrial homeostasis and mitochondria turnover. J Biol Chem 279:20699–20707PubMedCrossRefGoogle Scholar
  147. Szweda PA, Friguet B, Szweda LI (2002) Proteolysis, free radicals, and aging. Free Radic Biol Med 33:29–36PubMedCrossRefGoogle Scholar
  148. Tanahashi N, Murakami Y, Minami Y, Shimbara N, Hendil KB, Tanaka K (2000) Hybrid proteasomes. Induction by interferon-gamma and contribution to ATP-dependent proteolysis. J Biol Chem 275:14336–14345PubMedCrossRefGoogle Scholar
  149. Tanaka K (1994) Role of proteasomes modified by interferon-gamma in antigen processing. J Leukoc Biol 56:571–575PubMedGoogle Scholar
  150. Tanaka K, Yoshimura T, Ichihara A, Kameyama K, Takagi T (1986) A high molecular weight protease in the cytosol of rat liver. II. Properties of the purified enzyme. J Biol Chem 261:15204–15207PubMedGoogle Scholar
  151. Terman A, Sandberg S (2002) Proteasome inhibition enhances lipofuscin formation. Ann N Y Acad Sci 973:309–312PubMedCrossRefGoogle Scholar
  152. Unno M, Mizushima T, Morimoto Y, Tomisugi Y, Tanaka K, Yasuoka N, Tsukihara T (2002) The structure of the mammalian 20S proteasome at 2.75 A resolution. Structure 10:609–618PubMedCrossRefGoogle Scholar
  153. Vargas-Alarcon G, Gamboa R, Zuniga J, Fragoso JM, Hernandez-Pacheco G, Londono J, Pacheco- Tena C, Cardiel MH, Granados J, Burgos-Vargas R (2004) Association study of LMP gene polymorphisms in Mexican patients with spondyloarthritis. Hum Immunol 65:1437–1442PubMedCrossRefGoogle Scholar
  154. Vigouroux S, Briand M, Briand Y (2004). Linkage between the proteasome pathway and neurodegenerative diseases and aging. Mol Neurobiol 30:201–221PubMedCrossRefGoogle Scholar
  155. Viteri G, Carrard G, Birlouez-Aragon I, Silva E, Friguet B (2004) Age-dependent protein modifications and declining proteasome activity in the human lens. Arch Biochem Biophys 427:197–203PubMedCrossRefGoogle Scholar
  156. Voges D, Zwickl P, Baumeister W (1999) The 26S proteasome: a molecular machine designed for controlled proteolysis. Annu Rev Biochem 68:1015–1068PubMedCrossRefGoogle Scholar
  157. Wagner BJ, Margolis JW (1995) Age-dependent association of isolated bovine lens multicatalytic proteinase complex (proteasome) with heat-shock protein 90, an endogenous inhibitor. Arch Biochem Biophys 323:455–462PubMedCrossRefGoogle Scholar
  158. Wan SB, Landis-Piwowar KR, Kuhn DJ, Chen D, Dou QP, Chan TH (2005) Structure-activity study of epi-gallocatechin gallate (EGCG) analogs as proteasome inhibitors. Bioorg Med Chem 13:2177–2185PubMedCrossRefGoogle Scholar
  159. Webster RG (2000) Immunity to influenza in the elderly. Vaccine 18:1686–1689PubMedCrossRefGoogle Scholar
  160. Weissman AM (2001) Themes and variations on ubiquitylation. Nat Rev Mol Cell Biol 2, 169–178PubMedCrossRefGoogle Scholar
  161. Weksler ME, Szabo P (2000) The effect of age on the B-cell repertoire. J Clin Immunol 20:240–249PubMedCrossRefGoogle Scholar
  162. Whitby FG, Masters EI, Kramer L, Knowlton JR, Yao Y, Wang CC, Hill CP (2000) Structural basis for the activation of 20S proteasomes by 11S regulators. Nature 408:115–120PubMedCrossRefGoogle Scholar
  163. Xu B, Monsarrat B, Gairin JE, Girbal-Neuhauser E (2004) Effect of ajoene, a natural antitumor small molecule, on human 20S proteasome activity in vitro and in human leukemic HL60 cells. Fundam Clin Pharmacol 18:171–180PubMedCrossRefGoogle Scholar
  164. Yan LJ, Levine RL, Sohal RS (1997) Oxidative damage during aging targets mitochondrial aconitase. Proc Natl Acad Sci U S A 94:11168–11172PubMedCrossRefGoogle Scholar
  165. Yan LJ, Sohal RS (1998) Mitochondrial adenine nucleotide translocase is modified oxidatively during aging. Proc Natl Acad Sci U S A 95:12896–12901PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media B.V. 2009

Authors and Affiliations

  • Bertrand Friguet
    • 1
  1. 1.Laboratoire de Biologie Cellulaire du Vieillissement, UMR 7079Université Pierre et Marie CurieParisFrance

Personalised recommendations